Ion, I.; Renard, D.; Le Floch, A.; De Verdal, M.; Bouly, S.; Wacongne, A.; Lozza, A.; Castelnovo, G.
Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine. Toxins 2018, 10, 221.
https://doi.org/10.3390/toxins10060221
AMA Style
Ion I, Renard D, Le Floch A, De Verdal M, Bouly S, Wacongne A, Lozza A, Castelnovo G.
Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine. Toxins. 2018; 10(6):221.
https://doi.org/10.3390/toxins10060221
Chicago/Turabian Style
Ion, Ioana, Dimitri Renard, Anne Le Floch, Marie De Verdal, Stephane Bouly, Anne Wacongne, Alessandro Lozza, and Giovanni Castelnovo.
2018. "Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine" Toxins 10, no. 6: 221.
https://doi.org/10.3390/toxins10060221
APA Style
Ion, I., Renard, D., Le Floch, A., De Verdal, M., Bouly, S., Wacongne, A., Lozza, A., & Castelnovo, G.
(2018). Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine. Toxins, 10(6), 221.
https://doi.org/10.3390/toxins10060221